Abstract
Backgrounds
The optimal method for evaluating frailty grade in patients with cancer has not been established in patients undergoing esophagectomy for esophageal cancer. This study aimed to clarify the impact of cachexia index (CXI) and osteopenia on survival in esophagectomized patients for esophageal cancer to develop frailty grade for risk stratification of the prognosis.
Methods
A total of 239 patients who underwent esophagectomy were analyzed. CXI was calculated as follows: skeletal muscle index × serum albumin/neutrophil-to-lymphocyte ratio. Meanwhile, osteopenia was defined as below the cutoff value of bone mineral density (BMD) calculated by the receiver operating characteristic curve. We evaluated the average Hounsfield unit within a circle in the lower midvertebral core of the 11th thoracic vertebra on preoperative computed tomography as BMD.
Results
Multivariate analysis revealed that low CXI (Hazard ratio [HR], 1.95; 95% confidence interval [CI], 1.25–3.04) and osteopenia (HR, 1.86; 95% CI, 1.19–2.93) were independent prognostic factors for overall survival. Meanwhile, low CXI (HR, 1.58; 95% CI, 1.06–2.34) and osteopenia (HR, 1.57; 95% CI, 1.05–2.36) were also significant prognostic factors for relapse-free survival. A frailty grade combined with CXI and osteopenia stratified into four groups by their prognosis.
Conclusions
Low CXI and osteopenia predict poor survival in patients undergoing esophagectomy for esophageal cancer. Furthermore, a novel frailty grade combined with CXI and osteopenia stratified the patients into four groups according to their prognosis.
Similar content being viewed by others
References
Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA:Cancer J Clin 71(3):209–249
Fujita T, Sato K, Ozaki A et al (2022) Propensity-matched analysis of the short-term outcome of robot-assisted minimally invasive esophagectomy versus conventional thoracoscopic esophagectomy in thoracic esophageal cancer. World J Surg 46:1926–1933. https://doi.org/10.1007/s00268-022-06567-0
Yoshida N, Yamamoto H, Baba H et al (2020) Can minimally invasive esophagectomy replace open esophagectomy for esophageal cancer? latest analysis of 24,233 esophagectomies from the japanese national clinical database. Ann Surg 272:118–124
Argilés JM, Busquets S, Stemmler B et al (2014) Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 14:754–762
Sugimura K, Miyata H, Kanemura T et al (2022) Impact of preoperative skeletal muscle mass and physical performance on short-term and long-term postoperative outcomes in patients with esophageal cancer after esophagectomy. Ann Gastroenterol surg 6:623–632
Abe T, Oshikiri T, Goto H et al (2022) Albumin-derived NLR score is a novel prognostic marker for esophageal squamous cell carcinoma. Ann Surg Oncol 29:2663–2671
Hamura R, Haruki K, Shirai Y et al (2022) Preoperative cachexia index can predict the prognosis of extrahepatic biliary tract cancer after resection. Surg Oncol 44:101825
Verschueren S, Gielen E, O’Neill TW et al (2013) Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int 24:87–98
Zofková I (2008) Hormonal aspects of the muscle-bone unit. Physiol Res 57(Suppl 1):S159-169
Takahashi K, Nishikawa K, Furukawa K et al (2021) Prognostic significance of preoperative osteopenia in patients undergoing esophagectomy for esophageal cancer. World J Surg 45:3119–3128. https://doi.org/10.1007/s00268-021-06199-w
Brierley JDGM, Wittekind C (2016) TNM classification of malignant tumours, 8th edn. Wiley, New York
Kitagawa Y, Uno T, Oyama T et al (2019) Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1. Esophagus 16:1–24
Sharma P, Parikh ND, Yu J et al (2016) Bone mineral density predicts posttransplant survival among hepatocellular carcinoma liver transplant recipients. Liver Transpl 22:1092–1098
Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl 48:452–458
Hou YC, Wang CJ, Chao YJ et al (2018) Elevated serum interleukin-8 level correlates with cancer-related cachexia and sarcopenia: an indicator for pancreatic cancer outcomes. J Clin Med 7(12):502
Ábrigo J, Elorza AA, Riedel CA et al (2018) Role of oxidative stress as key regulator of muscle wasting during cachexia. Oxid Med Cell Longev 2018:2063179
Narsale AA, Carson JA (2014) Role of interleukin-6 in cachexia: therapeutic implications. Curr Opin Support Palliat Care 8:321–327
Brenner DA, Buck M, Feitelberg SP et al (1990) Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia. J Clin Investig 85:248–255
Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883–899
Zurlo IV, Schino M, Strippoli A et al (2022) Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer. Cancer Immunol, Immunother: CII 71:45–55
Sun Y, Zhang Y, Huang Z et al (2020) Combination of preoperative plasma fibrinogen and neutrophil-to-lymphocyte ratio (the F-NLR score) as a prognostic marker of locally advanced rectal cancer following preoperative chemoradiotherapy. World J Surg 44:1975–1984. https://doi.org/10.1007/s00268-020-05407-3
de Jong MC, Mihai R, Khan S (2021) Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as possible prognostic markers for patients undergoing resection of adrenocortical carcinoma. World J Surg 45:754–764. https://doi.org/10.1007/s00268-020-05868-6
Jones DH, Nakashima T, Sanchez OH et al (2006) Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440:692–696
Morony S, Capparelli C, Sarosi I et al (2001) Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis. Cancer Res 61:4432–4436
Roodman GD, Dougall WC (2008) RANK ligand as a therapeutic target for bone metastases and multiple myeloma. Cancer Treat Rev 34:92–101
D’Journo XB, Ouattara M, Loundou A et al (2012) Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancer. Dis Esophagus 25:527–534
Zanello SB, Collins ED, Marinissen MJ et al (1997) Vitamin D receptor expression in chicken muscle tissue and cultured myoblasts. Horm Metab Res 29:231–236
Pfeifer M, Begerow B, Minne HW (2002) Vitamin D and muscle function. Osteoporos Int 13:187–194
Lips P, van Schoor NM (2011) The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab 25:585–591
Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7:684–700
Müller K, Odum N, Bendtzen K (1993) 1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro. Immunol Lett 35:177–182
Gurlek A, Pittelkow MR, Kumar R (2002) Modulation of growth factor/cytokine synthesis and signaling by 1alpha,25-dihydroxyvitamin D(3): implications in cell growth and differentiation. Endocr Rev 23:763–786
Cheng SH, Chen KH, Chen C et al (2021) The optimal strategy of vitamin d for sarcopenia: a network meta-analysis of randomized controlled trials. Nutrients 13(10):3589
Acknowledgements
KT designed this research, acquired the data, and drafted this article. All authors read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There is no conflict of interest.
Ethical approval
The Ethics Committee in the Jikei University School of Medicine approved this study (33–303). The need for informed consent was waived because of the retrospective design of the study. All methods were performed in accordance with the ethical standards of the institutional review board of ethical committee with the Helsinki Declaration.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Takahashi, K., Masuda, T., Ishikawa, Y. et al. A Novel Frailty Grade Combined with Cachexia Index and Osteopenia in Esophagectomy. World J Surg 47, 1503–1511 (2023). https://doi.org/10.1007/s00268-023-06942-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-023-06942-5